ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
4,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
5,2,Headache,Headaches NEC,Headaches,Nerv,N
5,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
8,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
9,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
11,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
13,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
14,1,Headache,Headaches NEC,Headaches,Nerv,N
14,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
16,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
17,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
18,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
18,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
18,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
18,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
20,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
20,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
21,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
22,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
22,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
22,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
24,1,Urinary tract malformation,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
25,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
26,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
27,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
27,2,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
28,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
29,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
29,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,2,Headache,Headaches NEC,Headaches,Nerv,N
31,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
35,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
37,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
38,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
39,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
40,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
40,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
40,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
41,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
42,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
44,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
45,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
46,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
48,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
48,2,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
49,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
50,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
51,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
53,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
